Yahoo Web Search

Search results

1. • 

     Lilly (LLY) Hits Record High on Crohn's Disease Study Data

     Zacks via Yahoo Finance· 2 days ago

     Shares of Eli Lilly LLY rose nearly 3% on Tuesday after it reported detailed one-year results from...

2. • Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster

     The Motley Fool via AOL· 20 hours ago

     Eli Lilly (NYSE: LLY) can't stop grabbing headlines. The pharmaceutical company has made quite a bit of noise over the past few years thanks to notable clinical and regulatory ...

3. • Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual...

     FOX21 Colorado Springs· 10 hours ago

     Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearranged during transfection ...

4. • 

     Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...

     The Business Journals· 18 hours ago

     Aktis Oncology has landed a strategic collaboration with Eli Lilly (NYSE: LLY) aimed at developing...

5. • 3 Blue Chip Stocks That You Can Buy and Hold for Years

     The Motley Fool via AOL· 18 hours ago

     Here's a closer look at these stocks to see why they can make for solid investments in the long run. 1. Walmart It's hard to imagine a scenario where big-box retailer Walmart isn't a huge force ...

6. • 

     .../Diabetes Drug Tirzepatide Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co...

     Benzinga· 3 days ago

     On Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes...

7. • 

     Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

     Zacks via Yahoo Finance· 7 days ago

     Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their...

8. • 

     Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market?

     Motley Fool via Yahoo Finance· 5 days ago

     Eli Lilly (NYSE: LLY) sells a broad portfolio of products, but two in particular have helped revenue...

9. • 

     Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings

     Market Watch· 4 days ago

     jumped more than 30% Monday morning after the health and wellness platform said it would offer...

10. • 

      If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today

      Motley Fool via Yahoo Finance· 3 days ago

      Eli Lilly's (NYSE: LLY) broad portfolio of drugs has helped the company's earnings climb over the...